These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21715702)

  • 21. Effect of pramipexole in treatment of resistant restless legs syndrome.
    Lin SC; Kaplan J; Burger CD; Fredrickson PA
    Mayo Clin Proc; 1998 Jun; 73(6):497-500. PubMed ID: 9621854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
    Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
    Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the efficacy of pramipexole in patients with restless legs syndrome.
    Rezvani M; Zamani B; Fereshtehnejad SM
    Acta Med Iran; 2013 Jul; 51(6):377-85. PubMed ID: 23852842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
    Stiasny K; Röbbecke J; Schüler P; Oertel WH
    Sleep; 2000 May; 23(3):349-54. PubMed ID: 10811379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pregabalin with pramipexole for restless legs syndrome.
    Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
    N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
    Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
    Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP
    Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
    Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
    Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.
    Shinno H; Oka Y; Otsuki M; Tsuchiya S; Mizuno S; Kawada S; Innami T; Sasaki A; Hineno T; Sakamoto T; Inami Y; Nakamura Y; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):522-6. PubMed ID: 20156514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
    Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome.
    Jung KY; Kim SM; Song JY; Lee BU; Lee C; Lee SK; Koo YS; Cho YW; Choi JW; Kim KH
    Sleep Med; 2015 Jun; 16(6):703-8. PubMed ID: 25934537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
    Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
    Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodic leg movements in Cheyne-Stokes respiration.
    Manconi M; Vitale G; Ferri R; Zucconi M; Ferini-Strambi L
    Eur Respir J; 2008 Dec; 32(6):1656-62. PubMed ID: 19043012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome.
    Lai YY; Cheng YH; Hsieh KC; Nguyen D; Chew KT; Ramanathan L; Siegel JM
    Mov Disord; 2017 Dec; 32(12):1687-1693. PubMed ID: 28843017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pramipexole for the treatment of restless legs syndrome.
    Kushida CA
    Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G;
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of pramipexole in REM sleep behavior disorder: results from a case series.
    Schmidt MH; Koshal VB; Schmidt HS
    Sleep Med; 2006 Aug; 7(5):418-23. PubMed ID: 16815751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.